Family Med Medical News about Colitis, Ulcerative

Become a Member Today!
Register

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis
Inflammatory Bowel Disease, 11/04/09

Lukas M et al. – In the uncontrolled trial, administration of exogenous AP enzyme daily over a 7–day course to patients with UC was associated with short–term improvement in disease activity scores, with clinical effects being observed within 21 days and associated with reductions in C–reactive protein and stool calprotectin. AP enzyme treatment was well tolerated and nonimmunogenic.

<< Previous
Safety of immunomodulators and biologics for the treatment of...

Next >>
Diagnostic value of noninvasive combined fluorine-18 labeled...

Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09 Relevance Score: 70%

Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
ScienceDaily, 10/02/09 Relevance Score: 69%

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
Gastroenterology, 10/06/09 Relevance Score: 68%

Leukocyte apheresis in the management of ulcerative colitis
Saudi Journal of Gastroenterology, 10/05/09 Relevance Score: 68%

Ulcerative Colitis Treatment Reduces Need For Surgery By Almost Half, Study Suggests
ScienceDaily, 10/02/09 Relevance Score: 68%